Authors:
PIKE VW
AIGBIRHIO FI
FREEMANTLE CAJ
PAGE BC
RHODES CG
WATERS SL
JONES T
OLSSON P
VENTRESCA GP
TANNER RJN
HAYES M
HUGHES JMB
Citation: Vw. Pike et al., DISPOSITION OF INHALED 1,1,1,2-TETRAFLUOROETHANE (HFA134A) IN HEALTHY-SUBJECTS AND IN PATIENTS WITH CHRONIC AIR-FLOW LIMITATION - MEASUREMENT BY F-18 LABELING AND WHOLE-BODY GAMMA-COUNTING, Drug metabolism and disposition, 23(8), 1995, pp. 832-839
Authors:
AIGBIRHIO FI
PIKE VW
WATERS SL
TANNER RJN
Citation: Fi. Aigbirhio et al., EFFICIENT REGIOSELECTIVE LABELING OF THE CFC ALTERNATIVE 1,1,1,2-TETRAFLUOROETHANE (HFC-134A) WITH F-18, Journal of fluorine chemistry, 70(2), 1995, pp. 279-287
Authors:
MONTE SY
ISMAIL I
MALLETT DN
MATTHEWS C
TANNER RJN
Citation: Sy. Monte et al., THE MINIMAL METABOLISM OF INHALED 1,1,1,2-TETRAFLUOROETHANE TO TRIFLUOROACETIC-ACID IN MAN AS DETERMINED BY HIGH-SENSITIVITY F-19 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY OF URINE SAMPLES, Journal of pharmaceutical and biomedical analysis, 12(12), 1994, pp. 1489-1493
Citation: Vw. Pike et al., NOVEL USE OF AN ISOTOPE SEPARATOR TO DETERMINE THE POSITION OF F-18 IN LABELED 1,1,1,2-TETRAFLUOROETHANES, Organic mass spectrometry, 29(9), 1994, pp. 499-504
Citation: Mk. Ellis et al., METABOLIC-FATE AND DISPOSITION OF 1,1,1,2-TETRAFLUOROETHANE (HFC134A)IN RAT FOLLOWING A SINGLE EXPOSURE BY INHALATION, Xenobiotica, 23(7), 1993, pp. 719-729